相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue
Ryu Hiradate et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Experimental and computational study of naphthalimide derivatives: Synthesis, optical, nonlinear optical and antiviral properties
Santosh Kumar et al.
OPTIK (2021)
Chitosan modified by organo-functionalities as an efficient nanoplatform for anti-cancer drug delivery process
Shefali Jaiswal et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
Potentialities of selenium nanoparticles in biomedical science
Vanya Nayak et al.
NEW JOURNAL OF CHEMISTRY (2021)
Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy
Qian-Qian Fan et al.
BIOMATERIALS (2020)
Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
Ruifang Zhao et al.
FRONTIERS IN CHEMISTRY (2020)
Effects of Daily Consumption of an Aqueous Dispersion of Free-Phytosterols Nanoparticles on Individuals with Metabolic Syndrome: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Yasna K. Palmeiro-Silva et al.
NUTRIENTS (2020)
Dietary Strategies for Metabolic Syndrome: A Comprehensive Review
Sara Castro-Barquero et al.
NUTRIENTS (2020)
Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis
Xue Bai et al.
NANOMATERIALS (2020)
Cerium oxide nanoparticles: properties, biosynthesis and biomedical application
Kshitij R. B. Singh et al.
RSC ADVANCES (2020)
Substituted phenothiazines: synthesis and in silico evaluation of D4 dopamine receptor inhibition
Santosh Kumar et al.
SN APPLIED SCIENCES (2020)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus
Amira Mohamed Mohsen
CURRENT DRUG TARGETS (2019)
Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis
Yanping Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Nanotechnology-Mediated Drug Delivery for the Treatment of Obesity and Its Related Comorbidities
Yung-Hao Tsou et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Nanoformulations of natural products for management of metabolic syndrome
Yasamin Davatgaran Taghipour et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Low-Dose Curcumin Nanoparticles Normalise Blood Pressure in Male Wistar Rats with Diet-Induced Metabolic Syndrome
Ryan du Preez et al.
NUTRIENTS (2019)
Contribution of adipogenesis to healthy adipose tissue expansion in obesity
Lavanya Vishvanath et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Polymer-Based Nanoparticle Strategies for Insulin Delivery
Shazia Mansoor et al.
POLYMERS (2019)
Nanoparticle Delivery Systems in the Treatment of Diabetes Complications
Eliana B. Souto et al.
MOLECULES (2019)
Prevention of hepatic stellate cell activation using JQ1-and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis
Raghda Hassan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells
Jun Wu et al.
ADVANCED SCIENCE (2019)
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model
Martina Bruna Violatto et al.
ACS NANO (2019)
Nanotechnology advances towards development of targeted-treatment for obesity
Nicole Remaliah Samantha Sibuyi et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Recent advances in nanotechnology for the treatment of metabolic syndrome
Effat Bahadori et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Nanoparticle mediated silencing of tenascin C in hepatic stellate cells: effect on inflammatory gene expression and cell migration
Juan L. Vivero-Escoto et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment
Piyasi Mukhopadhyay et al.
CARBOHYDRATE POLYMERS (2018)
Resveratrol liposomes and lipid nanocarriers: Comparison of characteristics and inducing browning of white adipocytes
Yujiao Zu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Nanotechnology based approaches for anti-diabetic drugs delivery
Prashant Kesharwani et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Effect of nanoencapsulation using PLGA on antioxidant and antimicrobial activities of guabiroba fruit phenolic extract
Marina C. Pereira et al.
FOOD CHEMISTRY (2018)
Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis
Jian-Bin Qiao et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nanoliposomal Resveratrol as a Novel Approach to Treatment of Diabetes Mellitus
Cigdem Yucel et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2018)
Obesity Pathophysiology and Management
Kishore M. Gadde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity
Lars-Georg Hersoug et al.
NUTRITION RESEARCH REVIEWS (2018)
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer
Vikash Reebye et al.
ONCOGENE (2018)
Solid Lipid Nanoparticles of Myricitrin Have Antioxidant and Antidiabetic Effects on Streptozotocin-Nicotinamide-Induced Diabetic Model and Myotube Cell of Male Mouse
Akram Ahangarpour et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review
Atefeh Tajmohammadi et al.
PHYTOTHERAPY RESEARCH (2018)
Recent advances of polysaccharide-based nanoparticles for oral insulin delivery
Qiaobin Hu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Zinc oxide nanoparticles inhibit dimethylnitrosamine induced liver injury in rat
Varsha Rani et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers
Mohamed A. Morsy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism
Jahangir Iqbal et al.
CURRENT DIABETES REVIEWS (2018)
Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders
Biswanath Dinda et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs
Ruba Ismail et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status
Palanivel Ganesan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Postprandial Hyperlipidemia and Remnant Lipoproteins
Daisaku Masuda et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis
Nesrine S. El-Mezayen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles
Nadine Leber et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment
Chun Y. Wong et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers
Chih-Hung Lin et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2017)
Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
Mahmoud Hashemzaei et al.
ONCOLOGY REPORTS (2017)
Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-kappa B
Min Li et al.
ONCOLOGY RESEARCH (2017)
Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia
Lin Li et al.
PURINERGIC SIGNALLING (2017)
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
Max C. Petersen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Nanoformulations of curcumin: an emerging paradigm for improved remedial application
Meeta Gera et al.
ONCOTARGET (2017)
Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model
Rick A. Vreman et al.
BMJ OPEN (2017)
Nanodiamond enhances immune responses in mice against recombinant HA/H7N9 protein
Ngoc Bich Pham et al.
JOURNAL OF NANOBIOTECHNOLOGY (2017)
Resveratrol nano-capsule as an efficient tool for blood pressure regulation: A study on metabolic syndrome induced mice
Alemeh Shahraki et al.
BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS (2017)
Tolerogenic Nanoparticles to Treat Islet Autoimmunity
Tobias Neef et al.
CURRENT DIABETES REPORTS (2017)
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Yogita Rochlani et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2017)
Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-An in vitro and in vivo approach
Subhajit Maity et al.
CARBOHYDRATE POLYMERS (2017)
Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity
L. G. Hersoug et al.
OBESITY REVIEWS (2016)
Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers
Wei Shan et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins
Xi Zhu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery
Mariam Boushra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Curcumin-Zein Nanospheres Improve Liver Targeting and Antifibrotic Activity of Curcumin in Carbon Tetrachloride-Induced Mice Liver Fibrosis
Mardi M. Algandaby et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
Denise Oro et al.
JOURNAL OF HEPATOLOGY (2016)
Red Pepper (Capsicum baccatum)l Extracts Present Anti- Inflammatory Effects In Vivo and Inhibit the Production of TNF-α and NO In Vitro
Alexandra Allemand et al.
JOURNAL OF MEDICINAL FOOD (2016)
Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery
Mariam Boushra et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities
Chun Y. Wong et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Adipokines in bone disease
Elena Neumann et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo et al.
PHARMACEUTICAL RESEARCH (2016)
Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects
Feng Shi et al.
PHARMACOGNOSY MAGAZINE (2016)
Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
Xiaoxv Dong et al.
PHYTOTHERAPY RESEARCH (2016)
Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia
Kritika Sharma et al.
DRUG DELIVERY (2016)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia
Nicola Ferri et al.
ENDOCRINE (2016)
Epigenetics of obesity: beyond the genome sequence
Paul Cordero et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Ref lections From a Diabetes Care Editors' Expert Forum
William T. Cefalu et al.
DIABETES CARE (2015)
Evaluation of berberine/bovine serum albumin nanoparticles for liver fibrosis therapy
P. -L. Lam et al.
GREEN CHEMISTRY (2015)
Specific hepatic delivery of procollagen 1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis
Carolina Jimenez Calvente et al.
HEPATOLOGY (2015)
Glucose-responsive micelles for insulin release
Xiuhua Li et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives
Ning Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Nanomedicines for endothelial disorders
Bomy Lee Chung et al.
NANO TODAY (2015)
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation
Antonella Rocca et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents
Jiaolin Bao et al.
PLOS ONE (2015)
Managing diabetes with nanomedicine: challenges and opportunities
Omid Veiseh et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Intestinal Lipid Handling Evidence and Implication of Insulin Signaling Abnormalities in Human Obese Subjects
Alain Veilleux et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
What We Talk About When We Talk About Fat
Evan D. Rosen et al.
CELL (2014)
Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans
M. Miriam Jacome-Sosa et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin
Hyun-Jong Cho et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2014)
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Un Ju Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? - In the search for minimizing of the adverse effects of PAMAM administration
Magdalena Labieniec-Watala et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Insight into nanoparticle cellular uptake and intracellular targeting
Basit Yameen et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Comparative prophylactic effects of α-eleostearic acid rich nano and conventional emulsions in induced diabetic rats
Debjyoti Paul et al.
JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE (2014)
Peptide vectors for gene delivery: from single peptides to multifunctional peptide nanocarriers
Markus de Raad et al.
NANOMEDICINE (2014)
Oligopeptide complex for targeted non-viral gene delivery to adipocytes
Young-Wook Won et al.
NATURE MATERIALS (2014)
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
Miriam Mendez-del Villar et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
O-Hexadecyl-Dextran Entrapped Berberine Nanoparticles Abrogate High Glucose Stress Induced Apoptosis in Primary Rat Hepatocytes
Radhika Kapoor et al.
PLOS ONE (2014)
Engineered Silybin Nanoparticles Educe Efficient Control in Experimental Diabetes
Suvadra Das et al.
PLOS ONE (2014)
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics
L. Geurts et al.
BENEFICIAL MICROBES (2014)
LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells
Yao Dai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles
Xiuying Li et al.
BIOMATERIALS (2013)
Biomedical applications of carboxymethyl chitosans
Laxmi Upadhyaya et al.
CARBOHYDRATE POLYMERS (2013)
Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine
Indu Barwal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system
Azza A. Hasan et al.
DRUG DELIVERY (2013)
Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde
Djamel Tahtat et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin
Xiuhua Zhao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery
Er-Yuan Chuang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Nazila Kamaly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Glucose-responsive complex micelles for self-regulated release of insulin under physiological conditions
Hao Yang et al.
SOFT MATTER (2013)
Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE -/- mice
Gui-bo Sun et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Dyslipidemia in Obesity: Mechanisms and Potential Targets
Boudewijn Klop et al.
NUTRIENTS (2013)
O-Carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells
K. S. Snima et al.
CARBOHYDRATE POLYMERS (2012)
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration
Xiaoyan Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco et al.
HEPATOLOGY (2012)
Cellular and molecular effects of resveratrol in health and disease
Wei Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Polymeric Nanomaterials for Islet Targeting and Immunotherapeutic Delivery
Kaustabh Ghosh et al.
NANO LETTERS (2012)
Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin
Sanyog Jain et al.
NANOMEDICINE (2012)
The emerging role of HDL in glucose metabolism
Brian G. Drew et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Morphological and Functional Changes in the Retina after Chronic Oxygen-Induced Retinopathy
Shinsuke Nakamura et al.
PLOS ONE (2012)
A novel ternary NiFe2O4/CuO/FeO-chitosan nanocomposite as a cholesterol biosensor
Jay Singh et al.
PROCESS BIOCHEMISTRY (2012)
Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
Khalid A. Ansari et al.
AAPS PHARMSCITECH (2011)
Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults
Jui-Kun Chiang et al.
CARDIOVASCULAR DIABETOLOGY (2011)
The Portal Theory Supported by Venous Drainage-Selective Fat Transplantation
Julia M. Rytka et al.
DIABETES (2011)
Targeting Curcusomes to Inflammatory Dendritic Cells Inhibits NF-κB and proves Insulin Resistance in Obese Mice
Suman Kumar Yekollu et al.
DIABETES (2011)
The Concept of Metabolic Syndrome: Contribution of Visceral Fat Accumulation and Its Molecular Mechanism
Yuji Matsuzawa et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2011)
Triad of Metabolic Syndrome, Chronic Kidney Disease, and Coronary Heart Disease With a Focus on Microalbuminuria
Freij Gobal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Dietary phytochemicals and their potential effects on obesity: A review
Marta Gonzalez-Castejon et al.
PHARMACOLOGICAL RESEARCH (2011)
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles
Juliana M. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models
M. Pereira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Adipokines in inflammation and metabolic disease
Noriyuki Ouchi et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P. Dongiovanni et al.
GUT (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Effective protection and controlled release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles
Nan Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation
Shaoping Sun et al.
JOURNAL OF MICROENCAPSULATION (2010)
Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study
Monica Cavia-Saiz et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2010)
Oxidative stress and left ventricular remodelling after myocardial infarction
Masatsugu Hori et al.
CARDIOVASCULAR RESEARCH (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Roland Klingenberg et al.
EUROPEAN HEART JOURNAL (2009)
Formulation and characterization of an oily-based system for oral delivery of insulin
Amani Elsayed et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Baicalin Improves Antioxidant Status of Streptozotocin-Induced Diabetic Wistar Rats
Viduranga Y. Waisundara et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Naringenin protects against cadmium-induced oxidative renal dysfunction in rats
J. Renugadevi et al.
TOXICOLOGY (2009)
Statin Adverse Effects A Review of the Literature and Evidence for a Mitochondrial Mechanism
Beatrice A. Golomb et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Oral delivery of peptide drugs using nanoparticles self-assembled by poly(γ-glutamic acid) and a chitosan derivative functionalized by trimethylation
Fwu-Long Mi et al.
BIOCONJUGATE CHEMISTRY (2008)
Selective versus total insulin resistance: A pathogenic paradox
Michael S. Brown et al.
CELL METABOLISM (2008)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
Usefulness of cell-penetrating peptides to improve intestinal insulin absorption
Noriyasu Kamei et al.
JOURNAL OF CONTROLLED RELEASE (2008)
A novel insulin-sodium oleate complex for oral administration:: Preparation, characterization and in vivo evaluation
S. Sun et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2008)
Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure® in treating hyperlipidemia
A. K. Meena et al.
LIPIDS (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats
Leonor Rivera et al.
OBESITY (2008)
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
Amalia Gastaldelli et al.
GASTROENTEROLOGY (2007)
Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation
Da-Wei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites
Carmen S. L. Hoh et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Abdominal obesity: Role in the pathophysiology of metabolic disease and cardiovascular risk
Richard N. Bergman et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery
Yu-Hsin Lin et al.
BIOMACROMOLECULES (2007)
Timeline - The twentieth century struggle to decipher insulin signalling
Philip Cohen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes
Alin Stirban et al.
DIABETES CARE (2006)
Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review
Meera George et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Determination of scutellarin in mouse plasma and different tissues by high-performance liquid chromatography
F Xiong et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states
BR Barrows et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Metabolic syndrome: Focus on dyslipidemia
Henry N. Ginsberg et al.
OBESITY (2006)
Gold nanopartncles as carriers for efficient transmucosal insulin delivery
HM Joshi et al.
LANGMUIR (2006)
Pathophysiology of dyslipidaemia in the metabolic syndrome
GD Kolovou et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity
BE Wisse
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity
S Rashid et al.
CLINICAL BIOCHEMISTRY (2003)
Association of the metabolic syndrome with both vigorous and moderate physical activity
KL Rennie et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects
D Tripathy et al.
DIABETES (2003)
Adiponectin and development of type 2 diabetes in the Pima Indian population
RS Lindsay et al.
LANCET (2002)
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
G Pagano et al.
HEPATOLOGY (2002)
Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
AM Wallace et al.
CIRCULATION (2001)
Oral drug absorption enhancement by chitosan and its derivatives
M Thanou et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam
HC Brown et al.
NEUROLOGY (2000)
Adverse endothelial function and the insulin resistance syndrome
JE Tooke et al.
JOURNAL OF INTERNAL MEDICINE (2000)
分享论文
